Vantage Oncology

Vantage Oncology

Providing innovative radiation oncology solutions while enabling joint ventures for physicians and hospitals, ensuring advanced, accessible cancer treatments.

Founded 2002 10001+ employees Venture round Total: $74.50M Biotechnology, Health Care

Vantage Oncology, Inc. is a biotechnology and healthcare company founded in 2002. The company's slogan, "Providing innovative radiation oncology solutions while enabling joint ventures for physicians and hospitals, ensuring advanced, accessible cancer treatments," encapsulates its mission. Vantage Oncology offers a comprehensive suite of services for the development, implementation, and management of radiation oncology, catering to the increasing demand for accessible and advanced cancer treatment therapies. The company promotes joint venture ownership opportunities, allowing physicians to retain control of their practice while benefiting from Vantage Oncology's extensive network. Similarly, hospitals can opt for joint venture ownership to enhance their radiation oncology department. Their last investment was a Venture Round investment on 01 January 2012, led by HLM Venture Partners. This strategic investment highlights the confidence of industry leaders in Vantage Oncology's vision and potential impact in the field of radiation oncology.

Funding Stage	Amount	Investors	Lead Investors	Date
Venture Round	Undisclosed	1	HLM Venture Partners	01 Jan 2012
Series E	Undisclosed	2	New Enterprise Associates, Meritech Capital Partners	24 Jul 2008
Series D	$22.50M	5	New Enterprise Associates, Camden Partners +3	07 Feb 2007
Series C	$6.00M	4	New Enterprise Associates, Versant Ventures +2	28 Aug 2006
Series C	$22.00M	4	New Enterprise Associates, Versant Ventures +2	10 May 2005
Series B	$15.00M	4	New Enterprise Associates, Versant Ventures +2	23 Jun 2004
Series A	$9.00M	3	Versant Ventures, Conning Capital Partners +1	06 Nov 2002

Funding Stage

Amount

Investors

Lead Investors

Date

Venture Round

Undisclosed

HLM Venture Partners

01 Jan 2012

Series E

Undisclosed

New Enterprise Associates, Meritech Capital Partners

24 Jul 2008

Series D

$22.50M

New Enterprise Associates, Camden Partners +3

07 Feb 2007

Series C

$6.00M

New Enterprise Associates, Versant Ventures +2

28 Aug 2006

Series C

$22.00M

New Enterprise Associates, Versant Ventures +2

10 May 2005

Series B

$15.00M

New Enterprise Associates, Versant Ventures +2

23 Jun 2004

Series A

$9.00M

Versant Ventures, Conning Capital Partners +1

06 Nov 2002

FAQ About Vantage Oncology

Providing innovative radiation oncology solutions while enabling joint ventures for physicians and hospitals, ensuring advanced, accessible cancer treatments.

Vantage Oncology was founded in 2002.

Vantage Oncology operates in Biotechnology and Health Care. Its work centres on Radiation Oncology, Cancer Treatment, Joint Ventures and Physician Services.

Vantage Oncology has approximately 10001+ employees.

Vantage Oncology has completed 7 funding rounds, raising a total of $74.50M. The latest funding stage is Venture round.

Top alternatives and competitors to Vantage Oncology include Oncure Medical Corp, ViewRay, Inc., Mevion Medical Systems, Central Care Cancer Center, Cvergenx. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Vantage Oncology and Oncure Medical Corp are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Vantage Oncology

Funding Rounds & Investors (7)

Vantage Oncology Alternatives & Competitors

FAQ About Vantage Oncology